Login to Your Account



Other News To Note


Wednesday, October 19, 2011
NeurOp Inc., of Atlanta, was selected to participate in the 2011-2012 Commercialization Assistance Program (CAP) funded by the National Institutes of Health. The company is looking to CAP to help it refine a commercialization plan for its ischemia drug program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription